Overall rank by patents
#25,961
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61Q (SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS).
The verdict
Chanel holds 10 US patents across 4 technology areas, rank #25,961 of 50,000 tracked assignees.
Chanel has been granted 10 US utility patents between 2018 and 2024, placing Chanel at rank #25,961 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.6 claims per patent with primary concentration in A61Q (SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS). As a Foreign Corporation, Chanel is one of the more focused assignees in the PatentsView dataset. By volume, Chanel sits between Cellspect Co., Ltd. (10 patents, rank #25,957) and Chiscan Holdings, Llc (10 patents, rank #25,965) - the closest US assignees by grant volume. The composite Innovation Score of 21.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 2 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Chanel's 7.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Chanel against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CELLSPECT CO., LTD.
10 patents
CELLWIZE WIRELESS TECHNOLOGIES LTD.
10 patents
CENTERLINE BIOMEDICAL, INC.
10 patents
CENTRE FOR DEVELOPMENT OF TELEMATICS
10 patents
CHANGWON NATIONAL UNIVERSITY INDUSTRY ACADEMY COOPERATION CORPS
10 patents
CHIAN YIH OPTOTECH CO., LTD.
10 patents
CHINA FLASH CO., LTD.
10 patents
CHISCAN HOLDINGS, LLC
10 patents
CHANEL
10 patents
What this shows Chanel holds 10 patents at rank #25,961, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Chanel's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
22 Top 91% higher than 9% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2020 | 1 | 10.0% |
| 2021 | 5 | 50.0% |
| 2024 | 2 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#25,961
Across all tracked assignees
21.8 out of 100
How to use this portfolio
Chanel's 10 grants land it in the top 91% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.